2 Global Paediatric Vaccine Quarterly Market Size Analysis

• 2.1 Paediatric Vaccine Business Impact Assessment - COVID-19
  • 2.1.1 Global Paediatric Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Paediatric Vaccine Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Paediatric Vaccine Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Paediatric Vaccine Headquarters and Area Served
• 3.3 Date of Key Players Enter into Paediatric Vaccine Market
• 3.4 Key Players Paediatric Vaccine Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Paediatric Vaccine Segments, By Type

• 4.1 Introduction
  • 1.4.1 Pneumococcal
  • 1.4.2 Varicella
  • 1.4.3 Combinations
  • 1.4.4 Poliovirus
  • 1.4.5 Hepatitis
  • 1.4.6 MMR
  • 1.4.7 Pediatric Hormones
  • 1.4.8 HIB
  • 1.4.9 Allergy and Respiratory vaccines
  • 1.4.10 Other Pediatric vaccines
• 4.2 By Type, Global Paediatric Vaccine Market Size, 2019-2021

5 Impact of Covid-19 on Paediatric Vaccine Segments, By Application

• 5.1 Overview
  • 5.5.1 Age (0-3)
  • 5.5.2 Age (3-12)
  • 5.5.3 Age Above 12
• 5.2 By Application, Global Paediatric Vaccine Market Size, 2019-2021
  • 5.2.1 By Application, Global Paediatric Vaccine Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 GlaxoSmithCline
  • 7.1.1 GlaxoSmithCline Business Overview
  • 7.1.2 GlaxoSmithCline Paediatric Vaccine Quarterly Revenue, 2020
  • 7.1.3 GlaxoSmithCline Paediatric Vaccine Product Introduction
  • 7.1.4 GlaxoSmithCline Response to COVID-19 and Related Developments
• 7.2 Merck
  • 7.2.1 Merck Business Overview
  • 7.2.2 Merck Paediatric Vaccine Quarterly Revenue, 2020
  • 7.2.3 Merck Paediatric Vaccine Product Introduction
  • 7.2.4 Merck Response to COVID-19 and Related Developments
• 7.3 Sanofi
  • 7.3.1 Sanofi Business Overview
  • 7.3.2 Sanofi Paediatric Vaccine Quarterly Revenue, 2020
  • 7.3.3 Sanofi Paediatric Vaccine Product Introduction
  • 7.3.4 Sanofi Response to COVID-19 and Related Developments
• 7.4 Bristol-Myers Squibb
  • 7.4.1 Bristol-Myers Squibb Business Overview
  • 7.4.2 Bristol-Myers Squibb Paediatric Vaccine Quarterly Revenue, 2020
  • 7.4.3 Bristol-Myers Squibb Paediatric Vaccine Product Introduction
  • 7.4.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
• 7.5 Abbott Laboratories
  • 7.5.1 Abbott Laboratories Business Overview
  • 7.5.2 Abbott Laboratories Paediatric Vaccine Quarterly Revenue, 2020
  • 7.5.3 Abbott Laboratories Paediatric Vaccine Product Introduction
  • 7.5.4 Abbott Laboratories Response to COVID-19 and Related Developments
• 7.6 Eli Lilly
  • 7.6.1 Eli Lilly Business Overview
  • 7.6.2 Eli Lilly Paediatric Vaccine Quarterly Revenue, 2020
  • 7.6.3 Eli Lilly Paediatric Vaccine Product Introduction
  • 7.6.4 Eli Lilly Response to COVID-19 and Related Developments
• 7.7 Pfizer
  • 7.7.1 Pfizer Business Overview
  • 7.7.2 Pfizer Paediatric Vaccine Quarterly Revenue, 2020
  • 7.7.3 Pfizer Paediatric Vaccine Product Introduction
  • 7.7.4 Pfizer Response to COVID-19 and Related Developments
• 7.8 F. Hoffmann-La Roche
  • 7.8.1 F. Hoffmann-La Roche Business Overview
  • 7.8.2 F. Hoffmann-La Roche Paediatric Vaccine Quarterly Revenue, 2020
  • 7.8.3 F. Hoffmann-La Roche Paediatric Vaccine Product Introduction
  • 7.8.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
• 7.9 Novo Nordisk
  • 7.9.1 Novo Nordisk Business Overview
  • 7.9.2 Novo Nordisk Paediatric Vaccine Quarterly Revenue, 2020
  • 7.9.3 Novo Nordisk Paediatric Vaccine Product Introduction
  • 7.9.4 Novo Nordisk Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US

This report covers market size and forecasts of Paediatric Vaccine, including the following market information:
Global Paediatric Vaccine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Paediatric Vaccine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Paediatric Vaccine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Paediatric Vaccine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Pfizer, F. Hoffmann-La Roche, Novo Nordisk, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines

Based on the Application:
Age (0-3)
Age (3-12)
Age Above 12